Here is What Hedge Funds Think About Antares Pharma Inc (ATRS)

Due to the fact that Antares Pharma Inc (NASDAQ:ATRS) has encountered falling interest from the aggregate hedge fund industry, we can see that there lies a certain “tier” of funds that slashed their entire stakes last quarter. Interestingly, Benjamin A. Smith’s Laurion Capital Management cut the largest investment of the 700 funds studied by Insider Monkey, comprising about $0.5 million in stock. Hal Mintz’s fund, Sabby Capital, also dropped its stock, about $0.4 million worth.

Let’s go over hedge fund activity in other stocks – not necessarily in the same industry as Antares Pharma Inc (NASDAQ:ATRS) but similarly valued. We will take a look at Artesian Resources Corporation (NASDAQ:ARTNA), Miller Industries, Inc. (NYSE:MLR), Geospace Technologies Corp (NASDAQ:GEOS), and Sparton Corporation (NYSE:SPA). This group of stocks’ market values match ATRS’s market value.

As you can see these stocks had an average of 7 hedge funds with bullish positions and the average amount invested in these stocks was $28 million. That figure was $60 million in ATRS’s case. Sparton Corporation (NYSE:SPA) is the most popular stock in this table. On the other hand Artesian Resources Corporation (NASDAQ:ARTNA) is the least popular one with only 4 bullish hedge fund positions. Antares Pharma Inc (NASDAQ:ATRS) is not the most popular stock in this group but hedge fund interest is still above average. This is a slightly positive signal but we’d rather spend our time researching stocks that hedge funds are piling on. In this regard SPA might be a better candidate to consider taking a long position in.

Disclosure: None